The CLISTEPROBE biopsy device provides real-time diagnostic data during biopsy sampling, helping clinicians to make informed decisions by identifying benign and cancerous tissue. Developed by researchers at University College Cork and supported by Health Innovation Hub Ireland, the technology aims to reduce the stress and anxiety experienced by millions of women worldwide who undergo breast biopsies following suspicious mammograms. Waiting days or weeks for results, up to 80% of these biopsies turn out to be benign. The CLISTEPROBE device enhances point-of-care capabilities by integrating sensors, improving the accuracy and efficiency of biopsy procedures.
Source link
New Irish technology aims to reduce wait times for breast cancer screening results
